T. Rowe Price Associates’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Buy |
193,989
+7,439
| +4% | +$72.1K | ﹤0.01% | 1668 |
|
|
2025
Q1 | $2.78M | Buy |
186,550
+8,258
| +5% | +$123K | ﹤0.01% | 1466 |
|
|
2024
Q4 | $2.66M | Buy |
178,292
+15,064
| +9% | +$225K | ﹤0.01% | 1511 |
|
|
2024
Q3 | $3.12M | Buy |
163,228
+10,226
| +7% | +$196K | ﹤0.01% | 1442 |
|
|
2024
Q2 | $3.17M | Buy |
153,002
+7,797
| +5% | +$161K | ﹤0.01% | 1382 |
|
|
2024
Q1 | $2.73M | Buy |
145,205
+9,491
| +7% | +$178K | ﹤0.01% | 1432 |
|
|
2023
Q4 | $1.96M | Sell |
135,714
-213,819
| -61% | -$3.08M | ﹤0.01% | 1542 |
|
|
2023
Q3 | $6.07M | Hold |
349,533
| – | – | ﹤0.01% | 1144 |
|
|
2023
Q2 | $7.27M | Hold |
349,533
| – | – | ﹤0.01% | 1125 |
|
|
2023
Q1 | $8.22M | Buy |
349,533
+9,292
| +3% | +$219K | ﹤0.01% | 1090 |
|
|
2022
Q4 | $9.5M | Buy |
340,241
+3,036
| +0.9% | +$84.8K | ﹤0.01% | 1063 |
|
|
2022
Q3 | $7.89M | Sell |
337,205
-4,078
| -1% | -$95.4K | ﹤0.01% | 1105 |
|
|
2022
Q2 | $11.5M | Sell |
341,283
-173,955
| -34% | -$5.87M | ﹤0.01% | 1297 |
|
|
2022
Q1 | $18M | Sell |
515,238
-23,347
| -4% | -$815K | ﹤0.01% | 1250 |
|
|
2021
Q4 | $16.4M | Sell |
538,585
-4,991
| -0.9% | -$152K | ﹤0.01% | 1328 |
|
|
2021
Q3 | $17.8M | Sell |
543,576
-220,665
| -29% | -$7.24M | ﹤0.01% | 1333 |
|
|
2021
Q2 | $23.1M | Buy |
+764,241
| New | +$23.1M | ﹤0.01% | 1265 |
|